Guangzhi Gu
Key Laboratory Of Smart Drug Delivery, Lane 826, Zhangheng Road, Shanghai 201203, PR China
Shanghai, Puerto Rico
Shanghai, Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Journal: Molecular pharmaceutics
Published: December 04, 2013
B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.
Journal: Bioconjugate chemistry
Published: May 31, 2013
Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
Journal: Bioconjugate chemistry
Published: January 29, 2013
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Journal: Biomaterials
Published: January 17, 2013
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Journal: Biomaterials
Published: August 26, 2012
Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
Journal: International journal of nanomedicine
Published: August 14, 2012
Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.
Journal: International journal of pharmaceutics
Published: June 01, 2012
Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
Journal: International journal of pharmaceutics
Published: October 21, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026